Literature DB >> 20167556

Thrombin's central role in angiogenesis and pathophysiological processes.

Nikos E Tsopanoglou1, Michael E Maragoudakis.   

Abstract

A plethora of endogenous modulators of angiogenesis have been identified and their roles in the molecular and cellular events that mediate and regulate angiogenesis have been proposed. In this review, we summarize the recent findings on the role of thrombin/thrombosis on angiogenesis and other related pathophysiological processes. The mechanisms by which thrombin itself and its receptor PAR1 orchestrate many cellular events through interaction with a variety of other factors and cell types are discussed. These new data point to the complexity of the regulatory processes involved in the angiogenic cascade, which may be tissue specific, and dependent upon the pathology involved. The understanding of these events may provide targets for therapeutic intervention in disease states where angiogenesis is disturbed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20167556     DOI: 10.1684/ecn.2009.0166

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  7 in total

Review 1.  PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.

Authors:  Maya Zigler; Takafumi Kamiya; Emily C Brantley; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

2.  Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice.

Authors:  Kun Shi; Helene Damhofer; Joost Daalhuisen; Marieke Ten Brink; Dick J Richel; C Arnold Spek
Journal:  Mol Med       Date:  2017-02-06       Impact factor: 6.354

3.  Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography.

Authors:  Marina Marchetti; Erika Diani; Hugo ten Cate; Anna Falanga
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

4.  A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure.

Authors:  Anna Aronovich; Yaniv Nur; Elias Shezen; Chava Rosen; Yael Zlotnikov Klionsky; Irit Milman; Liran Yarimi; David Hagin; Gidi Rechavi; Uriel Martinowitz; Takashi Nagasawa; Paul S Frenette; Dalit Tchorsh-Yutsis; Yair Reisner
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

5.  RNA-seq reveals novel transcriptome of genes and their isoforms in human pulmonary microvascular endothelial cells treated with thrombin.

Authors:  Li Qin Zhang; Dilyara Cheranova; Margaret Gibson; Shinghua Ding; Daniel P Heruth; Deyu Fang; Shui Qing Ye
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

6.  Transcriptional Regulation of Thrombin-Induced Endothelial VEGF Induction and Proangiogenic Response.

Authors:  Rusan Catar; Guido Moll; Isa Hosp; Michele Simon; Christian Luecht; Hongfan Zhao; Dashan Wu; Lei Chen; Julian Kamhieh-Milz; Katarzyna Korybalska; Daniel Zickler; Janusz Witowski
Journal:  Cells       Date:  2021-04-15       Impact factor: 6.600

7.  Efficient therapy of ischaemic lesions with VEGF121-fibrin in an animal model of systemic sclerosis.

Authors:  Shadab Allipour Birgani; Marion Mailänder; Ines Wasle; Hermann Dietrich; Johann Gruber; Oliver Distler; Roswitha Sgonc
Journal:  Ann Rheum Dis       Date:  2015-09-11       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.